The enhancer rare germline variation rs548071605 contributes to lung cancer development. Issue 2 (11th December 2021)

• Record Type: Journal Article
• Authors: Wang, Xuchun; Cheng, He; Yang, Yin; Zuo, Xianglin; Shao, Lipei; Yu, Dawei; Yang, Nan; Zhang, Yu; Li, Ruilei; Wang, Xinyuan; Shen, Bin; Wang, Jianying; Shi, Xiao; Cao, Pingping; Sun, Luan; Han, Xiao; Sun, Yujie
• Is Part Of: Human mutation. Volume 43:Issue 2(2022)
• Page Start: 200
• Page End: 214
• Publication Date: 2021-12-11
• Subjects: enhancer -- LIF -- lung cancer -- missing heritability -- rare germline variation; Human chromosome abnormalities -- Periodicals; Mutation (Biology) -- Periodicals; 616.04205
• DOI: 10.1002/humu.24310
• Languages: English
• ISSNs: 1059-7794

Abstract

Abstract: Rare germline variations contribute to the missing heritability of human complex diseases including cancers. Given their very low frequency, discovering and testing disease‐causing rare germline variations remains challenging. The tag‐single nucleotide polymorphism rs17728461 in 22q12.2 is highly associated with lung cancer risk. Here, we identified a functional rare germline variation rs548071605 (A>G) in a p65‐responsive enhancer located within 22q12.2. The enhancer significantly promoted lung cancer cell proliferation in vitro and in a xenograft mouse model by upregulating the leukemia inhibitory factor ( LIF ) gene via the formation of a chromatin loop. Differential expression of LIF and its significant correlation with first progression survival time of patients further supported the lung cancer‐driving effects of the 22q‐Enh enhancer. Importantly, the rare variation was harbored in the p65 binding sequence and dramatically increased the enhancer activity by increasing responsiveness of the enhancer to p65 and B‐cell lymphoma 3 protein, an oncoprotein that assisted the p65 binding. Our study revealed a regulatory rare germline variation with a potential lung cancer‐driving role in the 22q12.2 risk region, providing intriguing clues for investigating the "missing heritability" of cancers, and also offered a useful experimental model for identifying causal rare variations.